Drug supply to NHS draws new UK antitrust probe (update*)
Supplies of pharmaceuticals to the UK’s National Health Service fell under antitrust scrutiny today, as the Competition and Markets Authority opened a new investigation. The CMA didn’t specify which drug was...To view the full article, register now.
Already a subscriber? Click here to view full article